HPV Rapid Test Strip (Urine)

HPV, or Human Papillomavirus, is one of the most common viral infections related to reproductive and sexual health. There are many HPV types. Some types are low-risk and may be associated with genital warts, while high-risk HPV types are linked with cervical cancer and other cancers. The HPV Rapid Test Strip is designed to support screening by detecting HPV-related markers in urine, depending on the product’s validated technology and instructions for use. Since HPV can often have no symptoms, screening support can be valuable for identifying possible infection risk and guiding follow-up care.

The HPV Rapid Test Strip (Urine) is intended for urine-based HPV screening support. It may help healthcare providers identify whether HPV-related markers are present in the urine sample, depending on the product’s validated performance.

Applications

• Women’s health screening
• Fertility and reproductive health clinics
• Gynecology departments
• STI screening centers
• Diagnostic laboratories
• Public health screening programs
• International diagnostic product distribution

The HPV Rapid Test Strip by LARKSOIS Pharma uses the colloidal gold method as per the product specification. Colloidal gold rapid tests generally use labeled particles to generate a visible line when the target marker is present in the sample.

Benefits

• Fast visual result format
• Simple urine sample workflow
• Non-invasive sample collection
• No complex instrument required for strip reading
• Compact strip format
• Suitable for screening programs and clinics
• Practical for international supply chains

The HPV Rapid Test Strip uses urine as the specimen. Urine collection is non-invasive, private, and more comfortable for many users than cervical sampling. This makes the HPV Rapid Test Strip (Urine) useful for clinics and public health programs aiming to improve screening access.

Guidance

• Collect urine in a clean and dry container
• Follow the exact sample volume and testing steps in the product insert
• Avoid contaminated or improperly stored urine samples
• Use the strip immediately after opening the sealed pouch
• Read the result only within the approved time window
• Do not reuse the test strip

Note

For LARKSOIS Pharma, the final website content should avoid unverified accuracy claims unless supported by LARKSOIS’s own test validation.

• HPV screening is important because persistent high-risk HPV infection can lead to cervical cell changes over time.
• The HPV Rapid Test Strip (Urine) may support wider screening access because it uses a urine sample rather than a cervical swab. This makes urine-based HPV screening especially relevant for global health markets, including regions where access to routine cervical screening is limited.
• However, the HPV Rapid Test Strip should not be positioned as a final cancer diagnosis. HPV infection does not mean cancer is present. A positive result should lead to appropriate medical consultation, confirmatory testing, and follow-up according to local screening guidelines.

Steps

• Bring the test strip and urine sample to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect urine in a clean and dry container
• Prepare the urine sample according to the product insert
• Dip or apply the sample to the strip according to instructions
• Place the strip on a clean, flat surface if required
• Read the result within the approved time window

Note

The exact testing procedure must follow the official LARKSOIS Pharma product insert or IFU supplied with the HPV Rapid Test Strip.

Positive

A positive result suggests that HPV-related markers have been detected in the urine sample. This does not mean the person has cervical cancer. It means follow-up testing or medical evaluation may be needed.

Negative

A negative result suggests that the target marker was not detected or was below the test’s detection level at the time of testing. A negative result does not fully rule out HPV infection if the sample was collected incorrectly or if the marker level was low.

Invalid

If the control indicator does not appear, the result is invalid. The test should be repeated with a new HPV Rapid Test Strip and fresh urine sample.

The HPV Rapid Test Strip (Urine) is a screening-support test. It should not replace professional medical advice, cervical screening, HPV DNA testing, Pap testing, or physician evaluation where those services are required.

Instructions

• Use only for in vitro diagnostic screening support
• Follow the official product insert carefully
• Do not use expired or damaged strips
• Do not reuse the test strip
• Avoid contaminated samples
• Interpret results within the recommended time only
• Confirm positive results through appropriate clinical evaluation

Note

Because HPV detection methods vary by assay type, LARKSOIS Pharma should clearly mention which HPV types or markers the product detects, the validated specimen type, the expected result time, and the test limitations.

Instructions

• Store in a clean and dry place
• Keep away from direct sunlight
• Do not freeze unless stated on the label
• Keep sealed until use
• Use before the expiry date
• Do not use if the pouch is damaged
• Follow the printed temperature range on the pack

Instructions

• For in vitro diagnostic screening support only
• Use urine specimen only as validated by the product insert
• Do not use as a final cancer diagnosis
• Do not replace cervical screening or medical evaluation where required
• Positive or uncertain results should be reviewed by a healthcare professional
• Use only within the approved reading time
• Follow local HPV screening and women’s health guidelines

LARKSOIS Pharma provides diagnostic products for international healthcare markets with a focus on accessibility, quality presentation, and professional screening support. The HPV Rapid Test Strip (Urine) is designed for buyers looking for a urine-based HPV screening product that is convenient, practical, and suitable for global distribution.

Advantages

• Urine-based HPV screening support
• Colloidal gold method
• Non-invasive specimen collection
• Compact strip format
• Suitable for women’s health and STI screening
• Useful for fertility clinics and diagnostic laboratories
• International product positioning under LARKSOIS Pharma